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Humaneptor (hIP) undergoes rapid agonist-induced internalization by largely unknown
mechanism(s). Herein the involvement of Rab5 in regulating cicaprost-induced internalization of the hIP
expressed in human embryonic kidney 293 cells was investigated. Over-expression of Rab5a signiﬁcantly
increased agonist-induced hIP internalization. Additionally, the hIP co-localized to Rab5a-containing
endocytic vesicles in response to cicaprost stimulation and there was a coincident net translocation of
Rab5 from the cytosol/soluble fraction of the cell. Co-immunoprecipitation studies conﬁrmed a direct
physical interaction between the hIP and Rab5a that was augmented by cicaprost. Whilst the dominant
negative Rab5aS34N did not show decreased interaction with the hIP or fully impair internalization, it
prevented hIP sorting to endocytic vesicles. Moreover, the GTPase deﬁcient Rab5aQ79L signiﬁcantly increased
internalization and co-localized with the hIP in enlarged endocytic vesicles. While deletion of the carboxyl
terminal (C)-tail domain of the hIP did not inhibit agonist-induced internalization, co-localization or co-
immunoprecipitation with Rab5a per se, receptor trafﬁcking was altered suggesting that it contains
structural determinant(s) for hIP sorting post Rab5-mediated endocytosis. Taken together, data herein and in
endothelial EA.hy 926 cells demonstrate a direct role for Rab5a in agonist-internalization and trafﬁcking of
the hIP and increases knowledge of the factors regulating prostacyclin signaling.
© 2008 Elsevier B.V.Open access under CC BY license.1. Introduction
The prostanoid prostacyclin, or prostaglandin (PG)I2, plays a prom-
inent role in vascular hemostasis, acting as a potent inhibitor of platelet
aggregation and as a vasodilator [1]. As one of the major products of
cyclooxygenase (COX)-2, it acts as a potent proinﬂammatory mediator
[2,3] and is abundantly produced during cardiac ischemia/reperfusion,
offering cytoprotection [4]. Perturbations in the levels of prostacyclin
and/or of the prostacyclin receptor (IP) have been associated with a
host of pathologies including thrombosis, stroke, ischemic heart
disease, systemic and pregnancy-induced hypertension [5–7]. The
critical role of prostacyclin to vascular integrity has been highlighted
through ﬁndings that certain COXIBs, the subclass of nonsteroidal anti-
inﬂammatory drugs designed to selectively inhibit COX-2, depress
prostacyclin generation predisposing patients to increased risk of
thrombotic stroke and myocardial infarction [8].
As amember of the G protein coupled receptor (GPCR) superfamily,
the prostacyclin receptor (IP) is primarily coupled to Gs/adenylylclathrin coated vesicles; FBS,
R, G protein-coupled receptor;
uman embryonic kidney; hIP,
53 1 2837211.
la).
 license.cyclase activation but may also couple to a range of other secondary
effectors in a cell and/or species speciﬁc manner [9–14]. The IP is
subject to a host of post-translational modiﬁcations that play a central
role in regulating its function. For example, the IP is somewhat unique
among members of the GPCR superfamily in that it is subject to both
isoprenylation and palmitoylation, lipid modiﬁcations that occur
within its carboxyl-terminal (C)-tail domain and which collectively
modulate its G-protein coupling and effector signaling [15–17].
A common feature of GPCR signaling is the regulation or de-
sensitization of second messenger generation and signaling that
occurs in response to the sustained agonist stimulation, dampening or
terminating the speciﬁc cellular response [18,19]. Such desensitization
is typically initiated by GPCR phosphorylation, uncoupling the
receptor from its cognate G-protein, and may lead to sequestration
and internalization of the desensitized GPCR from the plasma
membrane into intracellular compartments [18,19]. Whilst several
studies have established that the IP undergoes rapid agonist-induced
phosphorylation, internalization and down-regulation, such as in
human platelets and other cell types to critically modulate prostacy-
clin responses, the mechanism(s) by which the hIP undergoes such
internalization remains largely undetermined [20–24]. The classic
mechanism by which GPCRs undergo agonist-induced (homologous)
desensitization is initiated by G-protein-coupled receptor kinase
(GRK)-mediated phosphorylation. Thereafter, β-arrestin is recruited
to the GRK-phosphorylated receptor and acts as an adapter to target
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clathrin and the β2-adaptin subunit of the heterotetrameric AP2
adaptor complex [18,19]. Dynamin mediates the ﬁrst steps of
endosome formation at sites of clathrin-coated vesicles (CCVs) and
caveoli [25,26]. Rab proteins, the largest subgroup of the Ras
superfamily of GTPases, are involved in the regulation of vesicular
protein transport in endocytosis, trafﬁcking, endosome fusion and
exocytosis with each Rab having a distinct cellular localization and
role in the transport process [27–30]. Rab5 is localized to the plasma
membrane, CCVs and early endosomes [31] and has been shown to be
involved in the internalization of many GPCRs including the β2
adrenergic receptor [32,33], endothelin A and B receptors [34], the D2
dopamine receptor [35], the neurokinin-1 receptor [36] and the angio-
tensin II type 1A receptor [37].
Whilst the hIP undergoes direct agonist-induced PKC phosphoryla-
tion within its C-tail domain, desensitizing its signaling [23], agonist-
induced internalization of the hIP is completely independent of PKC
[24]. Moreover, while it was also established that agonist-induced
internalization of the hIP does not occur through the classic GRK/β-
arrestin mechanism [24], the internalized receptor was conﬁrmed to
co-localize to CCVs and internalizationwas impaired, at least inpart, by
inhibitors of clathrin-mediated trafﬁcking and of dynamin signaling
[24]. The carboxyl-terminal (C)-tail domain of a given GPCR can act as
an important determinant of receptor desensitization and internaliza-
tion, frequently enriched in Ser/Thr residues for phosphorylation and
containing structural motifs for interaction with components of
various trafﬁcking paths, such as β-arrestin or indeed Rab protein
binding domains [18,19,37,38]. In the case of the hIP, there is consider-
able controversy in the literature regarding the role of its C-tail domain
in its agonist-induced internalization [16,24,39,40]. Thus, in view of
the critical importance for the dynamic regulation of the cellular
responses to prostacyclin, such as within the vasculature, coupled to
the apparent controversy surrounding the actualmode of regulation of
those responses through IP internalization post-signaling, the aim of
the current study was to investigate the mechanisms of agonist-
induced internalization of the hIP and determine a role, if any, for the
Rab5GTPase in that internalization. Our data established that the hIP is
internalized in an agonist-dependent manner into Rab5a-containing
endosomes through a mechanism that promoted its sorting into
enlarged endocytic vesicles and involves a direct physical interaction
between the hIP and Rab5a.
2. Experimental procedures
2.1. Materials
Cicaprost was obtained from Schering AG (Berlin, Germany). [3H]iloprost was
purchased from Amersham Biosciences. Mouse monoclonal anti-hemagglutinin (HA)-
101R antibody (1 mg/ml) was obtained from Cambridge Biosciences; rabbit polyclonal
anti-Rab5 (S-19), rabbit polyclonal anti-GFP (FL), horse radish peroxidase (HRP)-
conjugated goat anti-rabbit and HRP-conjugated goat anti-mouse (400 μg/ml)
secondary antibodies were from Santa Cruz; rat monoclonal anti-HA 3F10-HRP-
conjugated antibody (25 μg/ml) was obtained from Roche. Anti HDJ-2 antibody was
from Neomarkers. AlexaFluor594 goat anti-mouse (2 mg/ml) and AlexaFluor488 goat
anti-rabbit (2 mg/ml) antibodies were from Molecular Probes. DAPI and Protein-G-
Sepharose were obtained from Sigma. The plasmid pcDNA3:HA:DynaminK44A was
kindly provided by Dr J. Benovic, Thomas Jefferson University, PA, USA.
2.2. Site-directed mutagenesis and subcloning
The plasmid pCMV5:Rab5a has been previously described [41]. Conversion of Ser34
to Asn34 of Rab5 to generate pCMV5:Rab5aS34N was achieved using pCMV5:Rab5a as
template and the sense/antisense primer pair (5VGTCC GCT GTT GGC AAA AATAGC CTA
GTG CTT CG). Conversion of Gln79 to Leu79 to generate pCMV5:Rab5aQ79L was achieved
using pCMV5:Rab5a as template and the sense/antisense primer pair (5V GG GAT ACA
GCT GGT CTT GAA CGA TAC CAT AGC C). Sequences shown correspond to the sense
primer and the identity of the mutator codon is in boldface italics. All site directed
mutagenesis was performed using QuikChange™ (Stratagene) system and were
validated by DNA sequence analysis. The full length cDNAs encoding Rab5a, Rab5aS34N,
Rab5aQ79L were subcloned in frame into the Xho1-BamH1 sites of pEGFPC1 to generate
pEGFPC1:Rab5a, pEGFPC1:Rab5aS34N and pEGFPC1:Rab5aQ79L, respectively.2.3. Cell culture and transfections
Human embryonic kidney (HEK) 293 cells were obtained from the American Type
Culture Collection andwere grown inminimal essential medium (MEM) containing 10%
foetal bovine serum (FBS).
Routinely approximately 48 h prior to transfection, HEK293 cells were plated at a
density of 2×106 cells/10 cm culture dish in 8 ml media. Thereafter, cells were
transiently transfected with 10 μg of pADVA [42] and 25 μg of pCMV- or pEGFPCI-based
vectors using the calcium phosphate/DNA co-precipitation procedure, as previously
described [43]. Transiently transfected cells were harvested 48 h after transfection,
unless otherwise stated.
HEK.hIPWT, HEK.hIPΔ312 and HEK.hIPΔ307 cells stably over-expressing HA-tagged
forms of hIPWT, hIPΔ312 and hIPΔ307, respectively, have been previously described [16,17].
HEK.β-galactosidase (HEK.β-Gal) cells stably over-expressing HA-tagged β-galactosi-
dase (β-Gal) from Escherichia coli were generated essentially as previously described
[15].
EA.hy 926 cells were obtained from the Tissue Culture Facility at UNC Lineberger
Comprehensive Cancer Center, North Carolina and were grown in Dulbecco's modiﬁed
Eagle's medium (DMEM) containing 10% FBS [44].
2.4. Radioligand binding studies
HEK.hIP, HEK. hIPΔ312, HEK.hIPΔ307 cells were harvested by centrifugation at 500 ×g
at 4 °C for 5 min and washed three times with phosphate-buffered saline (PBS). For
membrane preparation, cells were resuspended in homogenization buffer (25mM Tris–
HCl, pH 7.5, 0.25 M sucrose, 10 mM MgCl2, 1 mM EDTA, 0.1 mM phenylmethylsulfonyl
ﬂuoride), and membrane fractions were prepared by homogenization followed by
centrifugation (100,000 ×g, 40min at 4 °C). The pellet fraction (P100), representing crude
membranes, was resuspended in MES-KOH buffer (10 mM MES-KOH, pH 6.0, 10 mM
MnCl2, 1 mM EDTA, 10 mM indomethacin). IP radioligand binding assays were carried
out at 30 °C for 1 h using 100 µg of membrane protein (P100) in 100 µl reactions in the
presence of 4 nM [3H]iloprost (15.3 Ci/mmol) for saturation binding studies, or in the
presence of 0.1 nM–200 nM [3H] iloprost for Scatchard analysis, as described previously
[16,17].
2.5. Internalization of human prostayclin receptor (hIP) through ELISA
Cells were seeded at a density of 5×104 cells/ml per well in 1 ml of MEM, 10% FBS
media into 24-well plates, pre-coated with 0.001% poly-L-lysine, and were grown for
48 h at 37 °C prior to experiments. To assess agonist-induced internalization of hIP or its
mutated derivatives, the media was changed to serum-free MEM and thereafter, cells
were treated with cicaprost (1 μM, or for dose response, 0–10 μM) for 0, 0.5, 1, 1.5, 2, 3
and 4 h at 37 °C. Cells were washed twice in ice-cold PBS prior to ﬁxation in 3.7%
paraformaldehyde, TBS, pH 7.4, for 5 min at room temperature. After washing the cells
three times in TBS (20mM Tris–HCl, pH 7.4, 0.1 MNaCl), non-speciﬁc sites were blocked
with Blocking Buffer (1% bovine serum albumin, BSA, in TBS) for 1 h at room
temperature. Thereafter, cells were incubated with anti-HA 101R antibody (1: 2000 in
Blocking Buffer) for 1 h at room temperature. The antibody solution was removed and
the cells were washed three times in TBS, prior to incubation with goat anti-mouse HRP
(1: 2000) for 1 h at room temperature. Following this, the cells werewashed three times
in TBS and net changes in HA-tagged receptor cell surface expression were determined
colorimetrically at 650 nm using the K-Blue substrate (Neogen Corp) as previously
described [16].
For internalizations involving the co-expression of the various Rab proteins, HEK.
hIP, HEK. hIPΔ312, HEK.hIPΔ307 or, as controls, HEK 293 cells (10 cm dishes, 60–70%
conﬂuent) were transiently transfected with 10 μg of pADVA (Gorman and McCray,
1990) and 25 μg of pCMV:Rab5a, pCMV5:Rab5aS34N, pCMV5:Rab5aQ79, pcDNA3:
dynaminK44A or, as controls, the empty vector equivalents using the calcium
phosphate/DNA co-precipitation procedure, as previously described [43]. Some 24 h
post-transfection, cells were transferred to poly-L-lysine (0.001%) pre-coated 24-well
plates, at a density of 5×104 cells per well. Following 48 h incubation at 37 °C, cells were
stimulated as indicated in the ﬁgure legends and the ELISA assay carried out to
determine levels of cell surface expression of HA-tagged hIPs, as previously described.
2.6. Indirect immunoﬂuorescence microscopy
To monitor expression of the hIP by indirect immunoﬂuorescence, HEK.hIP cells
were grown to 60–70% conﬂuency on poly-L-lysine pre-treated coverslips in 6-well
plates. Thereafter, cells were washed in serum-free medium (MEM) and incubated with
either vehicle (MEM) or 1 μM cicaprost, in MEM, for 2 h at 37 °C. Cells were washed
twice in ice-cold PBS prior to ﬁxation in 3.7% paraformaldehyde, PBS, pH 7.4, for 15 min
at room temperature. After washing three times in PBS, cells to be permeabilized were
incubated with 0.2% Triton X-100 in PBS for 10 min on ice followed by washing in three
times in TBS. Non-speciﬁc sites were blocked by incubating cells with Blocking Buffer
(1% BSA in TBS) prior to immunolabeling with anti-HA 101R (1:1000 dilution in
Blocking Buffer) for 1 h. Unbound antibody was then removed by washing twice in TBS
followed by detection with the secondary AlexaFluor594 goat anti-mouse antibody
(1:5000, in 1% BSA, TBS). Cells were washed three times in TBS, prior to counterstaining
with DAPI (1 μg/ml, in H2O). Excess DAPI was washed away with H2O prior to mounting
coverslips in DakoCytomation ﬂuorescence mounting medium.
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In order to monitor changes in cell-surface expression of the hIP as a function of
cicaprost-stimulation and/or colocalization with Rab5, HEK.hIP cells were transiently
transfected with 10 μg of pADVA and 25 μg of pEGFPC1:Rab5a, pEGFPC1:Rab5aS34N,
pEGFPC1:Rab5aQ79L, encoding green ﬂuorescent protein (GFP)-tagged forms of the Rab
proteins using the calcium phosphate/DNA co-precipitation procedure [43]. Some 24 h
later, cells were seeded onto poly-L-lysine pre-treated coverslips in 6-well plates to
achieve 60–70% conﬂuency following 48 h incubation at 37 °C. Thereafter, the cells were
washed in serum-free MEM and then pre-incubated with anti-HA 101R (1:1000
dilution in MEM) at 4 °C for 1 h to label cell surface receptors. Unbound antibody was
removed by washing twice with MEM following which cells were either analysed
immediately (0 h) or were incubated with 1 μM cicaprost in MEM for 0–4 h, as
indicated, at 37 °C. Cells were then washed twice in ice-cold PBS prior to ﬁxation and
permeabilization, as described above. Non-speciﬁc sites were blocked and HA-tagged
receptors were immunolabelled with the secondary AlexaFluor594 goat anti-mouse
antibody, as described. In order to examine cicaprost-dependent changes in hIP cell-
surface expression and/or colocalization with endogenous Rab5, untransfected HEK.hIP
cells were preimmunolabeled with anti-HA 101R (1:1000 dilution in MEM; 4 °C for 1 h)
prior to agonist stimulation (1 μM cicaprost; 0–4 h) as described above. After ﬁxation
and permeabilization, non-speciﬁc sites were blocked followed by immunolabelling of
endogenous Rab5 with anti-Rab5 (S-19). Thereafter, HA-tagged receptors and
endogenous Rab5 were immunolabelled with the secondary AlexaFluor594 goat anti-
mouse and AlexaFluor488 goat anti-rabbit antibodies, respectively, as described.
Similarly, EA.hy 926 cells were treated with 1 μM cicaprost prior to ﬁxation,
permeabilization and immunolabelling with anti-Rab5 and secondary AlexaFluor488
goat anti-rabbit antibodies. All slides were imaged, at ×63 magniﬁcation, using Carl
Zeiss Lazer Scanning System LSM510 and Zeiss LSM Imaging software for acquiring
multichannel images with ﬁlters appropriate for enhanced GFP, AlexaFluor488 and
AlexaFluor 594 ﬂuorescence.
2.8. Subcellular fractionation
HEK.hIP cells (approx 2×106 cells in 8 ml MEM, 10% FBS) were plated on 10-cm
dishes some 48 h previously to achieve approximately 75% conﬂuency. Thereafter, cells
were washed and incubated in serum-free MEM for 1 h prior to treatment with 1 μM
cicaprost for 0, 0.5, 1, 2, 3 or 4 h. While retaining an aliquot of total protein for SDS-PAGE
analysis, subcellular fractionation was carried out on the remaining sample. Brieﬂy, cell
pellets were resuspended in homogenization buffer (25 mM Tris–Cl, pH 7.5, 0.25 M
sucrose, 10 mM MgCl2, 1 mM EDTA, 0.1 M PMSF) and homogenized on ice for 1 min
(approximately 20 strokes) prior to centrifuging samples at 100,000 ×g for 60min at 4 °C.
The soluble, supernatant (S100 fraction) was retained for analysis and the pellet (P100
fraction) was ﬁrst washed in MES-KOH buffer (10 mMMES-KOH, pH 6.0, 10 mMMnCl2,
1 mMEDTA,10mM indomethacin) prior to resuspension in 10mMTris–Cl, 1mM EDTA.,
pH 8.0. The protein concentrations were determined by the Bradford assay. Aliquots of
the Total, S100 and P100 protein fractions (50 μg per lane) were resolved by SDS-PAGE, on
12.5% gels, and subject to immunoblotting with anti-Rab5 antibody (1:1000) followed
by anti-HDJ-2 (1:4000) antibody, with chemiluminescence detection [15]. To quantify
changes in Rab5 expression in the S100 fractions as a function of cicaprost stimulation (h),
all images of Rab5 expression in the S100 fractionswere captured using Adobe Photoshop
(V6), where bandwidth and intensity was quantiﬁed. Thereafter, Rab5 expression in the
S100 fractions at the various time points was expressed as a percentage of that in the
absence of cicaprost (Rab5 Expression in S100; % Expression±S.E.M., n=3).
2.9. Co-Immunoprecipitations
HEK.hIPwt, HEK.hIPΔ312, HEK.hIPΔ307and, as controls, HEK.293 or HEK.β-galactosi-
dase (β-Gal) cells, were transiently co-transfected with pADVA and either pEGFPC1,
pEGFPC1:Rab5a, pEGFPC1:Rab5aS34N or pEGFPC1:Rab5aQ79L, using the calcium phos-
phate/DNA co-precipitation procedure [43]. Some 48 h post-transfection, cells were
washed in serum-free MEM and either incubated with vehicle (serum-free MEM) or
with 1 μM cicaprost in serum-free MEM for 2 h at 37 °C, or as indicated in the ﬁgure
legends. Thereafter, the incubation was stopped by washing the cells twice in ice-cold
PBS followed by lysis in 500 μl radio-immune precipitation buffer (RIP; 50 mM Tris HCl,
pH 8.0, 150 mMNaCl, 1 mM EDTA, 1% Nonidet P-40 (v/v), 0.5% sodium deoxycholate (w/
v), 0.1% SDS (w/v), 10 mM sodium ﬂuoride, 25 mM sodium pyrophosphate, 1 mM PMSF,
4 µg/ml leupeptin, 2.5 µg/ml aprotinin). Lysates were clariﬁed by centrifugation at
13,000 rpm for 5 min and 50 μl (approx 50 μg) retained for analysis of protein
expression in whole cell lysates. The remaining lysate was used for immunoprecipita-
tion, using anti-HA 101R antibody (1:300) to pull-down HA-tagged hIP(s) through
overnight incubation at 4 °C with mixing on a rotissary. Thereafter, the lysates were
incubated for 1 h with 10 µl of 50% slurry of protein G Sepharose, prior to washing.
Immunoprecipitates were resolved by SDS-PAGE, on 10% gels, and subjected to
successive immunoblotting with anti-Rab5 (1:1000), anti-GFP (1:1000) and anti-HA
3F10-HRP (1:500) antibodies.
2.10. Data analyses
Statistical analyses were carried out using the unpaired Student's t test throughout
or, where relevant and speciﬁcally indicated in text, using two-way ANOVA employingthe GraphPad Prism (version 4.00) package. p-values of less than or equal to 0.05 were
considered to indicate a statistically signiﬁcant difference.
3. Results
3.1. Effect of Rab5 on agonist-induced internalization of the human
prostacyclin receptor, hIP
Whilst the human prostacyclin receptor (hIP) undergoes rapid
agonist-induced phosphorylation and desensitization of signaling, it
has also been widely reported to undergo agonist-induced inter-
nalization through, as yet, largely unknown mechanism(s). Hence, we
sought to elucidate the mechanism of agonist-induced internalization
of the hIP stably expressed in human embryonic kidney (HEK) 293
cells in response to its selective agonist cicaprost. To begin with, we
used an ELISA-based internalization assay to measure net changes in
cell surface expression of hemagglutinin (HA)-tagged hIPs in response
to cicaprost stimulation of HEK.hIP cells, a previously characterized
clonal cell line [15,17]. The hIP underwent cicaprost-induced inter-
nalization in a biphasic manner, with rapid internalization observed
during the ﬁrst 60 min and, thereafter, reached a plateau or reduced
rate up to 3 h such that, in all, approximately 40% of cell surface hIP
underwent internalization following 3 h stimulation (61.2±2.15% cell
surface expression; Fig. 1A). Thereafter, the overall level of hIP ex-
pression at the cell surface increased signiﬁcantly with some 76.6±
1.76% expressed on the cell surface at 4 h post cicaprost stimulation,
suggesting that approximately 50% of the internalized hIP may recycle
back to the cell surface with time. The inclusion of the general protein
synthesis inhibitor cycloheximide did not affect the overall pattern or
proﬁle of cicaprost-induced internalization by the hIP, conﬁrming that
the increased cell surface expression observed at 4 h was due to
receptor recycling or trafﬁcking from intracellular pools and not due to
de novo protein synthesis (data not shown). Internalization was also
concentration dependent with 2×10−7 M cicaprost required to bring
about a 20% decrease in hIP expression on the cell surface (i.e.
concentration required to induce internalization of 50% of internaliz-
able hIPs; Fig. 1B). Furthermore, immunoﬂuorescence and confocal
imaging showed that in resting HEK.hIP cells, the hIP is predominantly
expressed on the cell surface as demonstrated in both non-per-
meabilized and permeabilized cells, with evidence from the latter that
some of the hIP is also expressed intracellularly (Fig. 1C, upper panels).
Stimulation of HEK.hIP cells with 1 μM cicaprost (2 h at 37 °C) led to a
signiﬁcant decrease in the expression of the hIP detected at the cell
surface under non-permeabilizing conditions (Fig. 1C). Concomitant
with this, under permeabilizing conditions, there was a substantial
increase in the intracellular expression of the hIP, notably to large
punctate vesicular-type structures reminiscent of clathrin-coated
vesicles (CCV) and early endosomes (Fig. 1C, lower panels).
While the most prevalent, and indeed best characterized, pathway
by which GPCRs internalize in response to agonist-stimulation is via
the classic GRK-mediated phosphorylation/β-arrestin-dependent
mechanism leading to internalization on clathrin-coated and non-
clathrin coated vesicles, as stated, agonist-induced internalization of
the hIP is independent of the GRKs/β-arrestins but is dependent on
clathrin and, partially, dependent on dynamin [24]. The GTPase Rab5
is also widely reported to participate in the internalization and/or
recruitment of numerous GPCRs to clathrin-coated, Rab5 containing
early endosomes [33–36]. Therefore, in view of the signiﬁcant agonist-
induced relocalization of the hIP away from the plasma membrane to
the large intracellular vesicular or endosomal structures, as was
evident from our immunolocalization data (Fig. 1C), we investigated
the possible involvement of Rab5 in the internalization of the hIP.
Hence, initially herein, the effect of over-expression of Rab5a on
agonist-induced internalization of the hIP was examined using an
ELISA-based internalization assay to monitor over-all changes in cell-
surface hIP. The expression of signiﬁcant levels of both endogenous
Fig. 1. Cicaprost-induced Internalization of thehuman Prostacyclin Receptor (hIP). Panels A andB:HEK.hIP cellswere incubated at 37 °Cwith 1 μMcicaprost for 0–4h (panel A) orwith 0–
10 μMcicaprost for 4 h (panel B). Panels E–G:HEK.hIP cells transiently transfectedwith either the control vector pcDNA3 (panel E), pCMV5:Rab5a (panels E–G), pCMV5:Rab5aS34N (panel
F) or pCMV5:Rab5aQ79L (panel G) were incubated with 1 μM cicaprost at 37 °C for 0–4 h. Panel H, HEK.hIP cells, transiently transfected with pcDNA3:dynaminK44A, pCMV5:Rab5a plus
pcDNA3:DynaminK44A orwith pcDNA3were incubated at 37 °Cwith 1 μMcicaprost for 0–4h. Panels A, B, E–H: expression of cell surfaceHA-taggedhIPswasdetected by ELISAusing anti-
HA101Rantibody. Results are eitherexpressed asmean cell surface expression as a percentage of that at 0 h (% cell surface expression±S.E.M.) as a functionof time (h) orof Log10 cicaprost
concentration (M; panel B) and, in each case, are representative of at least three independent experiments each carried out in triplicate. Panel C: HEK.hIP cellswere preincubatedwith the
drug vehicle (vehicle) or with 1 μM cicaprost for 2 h at 37 °C (Cicaprost); thereafter cells were immunolabelled using anti-HA 101R antibody under either non-permeabilizing and
permeabilizing conditions. Images (n=3) were captured using Carl Zeiss Lazer Scanning System LSM510 and Zeiss LSM Imaging software. The horizontal bar represents 10 μm. Panel D:
HEK.hIP cells transiently transfected with either pcDNA3 (lane 1), pCMV5:Rab5a (lane 2), pCMV5:Rab5aS34N (lane 3) or pCMV5:Rab5aQ79L (lane 4) were analyzed by SDS-PAGE (50 μg
whole cell protein per lane) followed by immunoblotting using anti-Rab5 antibody. Data presented is a representative immunoblot from 3 independent experiments. The reader is
referred to the web version of this article to see color images of this ﬁgure, where relevant.
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(Fig. 1D) and indeed in the parental HEK 293 cell line (data not shown)
was initially conﬁrmed by western blot analysis. While over-expres-
sion of Rab5a did not affect the initial rate or overall biphasic pattern
of cicaprost-induced internalization of the hIP in HEK.hIP cells relative
to that in non-transfected (Fig. 1A) or cells transfected with the empty
control vector pcDNA3 (Fig. 1E), it signiﬁcantly increased the overalllevel of hIP internalization (Fig. 1E, pb0.0001; two-way ANOVA), with
most signiﬁcance at 2 and 3 h (Fig. 1E; p=0.005 and p=0.0076,
respectively). Moreover, while over-expression of a dominant nega-
tive form of Rab5a, namely Rab5aS34N, did not appear to affect the
initial rate or overall biphasic proﬁle of cicaprost-induced hIP
internalization over the 4 h incubation period, it signiﬁcantly impaired
hIP internalization relative to that of the wild type Rab5a (Fig. 1F;
Fig. 2. Cicaprost-induced Co-localization of the hIP and Rab5a, Rab5aS34N or Rab5aQ79L. HEK.hIP cells, transiently transfected with either pEGFPC1:Rab5a (panel A), pEGFPC1:
Rab5aS34N (panel B), pEGFPC1:Rab5aQ79L (panel C) were pre-labelled with anti-HA 101R primary antibody for 1 h at 4 °C; thereafter, cells were either analyzed directly (0 h) or were
incubated at 37 °C for 2 h with 1 μM cicaprost (2 h), as indicated. Cells were ﬁxed and permeabilized prior to detection of HA-tagged hIPs, with anti-mouse AlexaFluor594 conjugated
secondary antibody, and enhanced GFP:Rab5 expression using a Carl Zeiss Lazer Scanning System LSM510 and Zeiss LSM Imaging software. Data presented are representative images
from 3 independent experiments fromwhich at least 10 ﬁelds were viewed at ×63magniﬁcation, where the horizontal bar represents 10 μm. The reader is referred to theweb version
of this article to see color images of this ﬁgure.
1918 M.B. O'Keeffe et al. / Biochimica et Biophysica Acta 1783 (2008) 1914–1928p=0.0003; ANOVA), with most signiﬁcance at 2 and 3 h (Fig. 1E;
p=0.05 and p=0.0001, respectively). The fact that there is such
abundant expression of endogenous Rab5 in HEK.hIP cells may explain
why Rab5aS34N did not result in a more substantial inhibition of
internalization of the hIP (Fig. 1F). Conversely over-expression of the
constitutively active Rab5aQ79L led to signiﬁcantly increased cicaprost-
induced hIP internalization compared to non-transfected or control
cells transfected with pcDNA (p=0.0005; ANOVA), but Rab5aQ79L did
not alter the overall proﬁle or extent of that hIP internalization relativeto the wild type Rab5 (Fig. 1G, p=0.6718). However, Rab5aQ79L did
appear to impair recycling of the hIP to the plasma membrane at the
4 h time point (Fig. 1G; p=0.039).
In a previous study, Smyth et al., established that iloprost-mediated
internalization of hIP was also partially reduced by over-expression of a
dominant negative form of dynamin, namely DynK44A [24]. Hence, in
view of our ﬁndings herein involving Rab5, we sought to determine
whether expression of DynK44A alone or DynK44A along with Rab5aS34N
might affect the overall level of cicaprost-induced hIP internalization.
Fig. 3. Cicaprost-induced Co-localization of the hIP and Rab5a. HEK.hIP cells, transiently transfected with the pEGFPC1:Rab5a, were pre-labelled with the anti-HA 101R antibody for
1 h at 4 °C, prior to stimulation with vehicle or 1 μM cicaprost at 37 °C for 0–4 h. Cells were ﬁxed and permeabilized prior to detection of HA-tagged hIPs, with anti-mouse
AlexaFluor594 conjugated secondary antibody, and enhanced GFP:Rab5a expression using Carl Zeiss Lazer Scanning System LSM510 and Zeiss LSM Imaging software. Data presented
are representative images from 3 independent experiments fromwhich at least 10 ﬁelds were viewed at ×63 magniﬁcation, where the horizontal bar represents 10 μm. The reader is
referred to the web version of this article to see color images of this ﬁgure.
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ﬁrmed bywestern blot analysis (data not shown). Moreover, expression
of DynK44A signiﬁcantly decreased the extent of cicaprost-induced
internalization of the hIP relative to control (pcDNA)-transfected cells
(Fig. 1H; pb0.0001; ANOVA). Similarly, while co-expression of both
DynK44A along with Rab5aS34N impaired cicaprost-induced internaliza-
tion in HEK.hIPWT cells relative to pcDNA-transfected cells (Fig. 1H,
pb0.0001; ANOVA), co-expression of both factors together did not
signiﬁcantly impair internalization relative to Rab5aS34N alone (Fig. 1F,
p=0.27; ANOVA) or DynK44A alone (Fig. 1H, p=0.8068; ANOVA). Hence,
the lack of an accumulative effect of DynK44A and Rab5aS34N on
inhibition of agonist-induced internalization of the hIP, suggests that
dynamin and Rab5a regulate that internalization through a common
pathway rather than through 2 separate or independent pathways.3.2. Agonist-induced colocalization of internalized hIP to Rab5 endosomes
To further assess the role of Rab5, HEK.hIP cells were transiently
co-transfected with plasmids encoding green ﬂuorescent protein
(GFP)-tagged forms of Rab5a, Rab5aS34N or Rab5aQ79L and cicaprost-
induced internalization of the cell-surface of HA-tagged hIP and
possible co-localizationwith Rab5a examined by confocal microscopy.
Speciﬁcally, cell surface HA-tagged receptors in HEK.hIP cells were
initially pre-immunolabelled at 4 °C with the anti-HA 101R antibody;
thereafter, HA-hIP expression was either analyzed directly (0 h
internalization) or following incubation of cells with 1 μM cicaprost
for 2 h at 37 °C (2 h post-agonist stimulation). In the absence of agonist
stimulation, immunolabelled HA-hIPs were expressed at the cell
surface as expected whereas GFP-Rab5a was localized to distinct
Fig. 4. Cicaprost-induced Sub-cellular Translocation of Rab5. Panel A: HEK.hIP cells were incubated with 1 μM cicaprost for 0, 30 min, 1, 2, 3 and 4 h at 37 °C in serum-free media prior
to homogenization and subcellular fractionation into their respective particulate (P100) or soluble (S100) fractions following centrifugation at 100,000 ×g for 1 h at 4 °C. Aliquots (50 μg
protein per lane) of the resulting total, P100 and S100 protein fractions were resolved by SDS-PAGE and initially immunoblotted (IB) with anti-Rab5 antibody (upper panels); followed
by anti-HDJ-2 antibody (lower panels). Results presented are representative from 3 independent experiments. The relative positions of the 30 kDa and 45 kDamolecular size markers
are indicated to the left of the panels. Panel B: Rab5 expression in the S100 fractions at the various time points following cicaprost stimulation (h) as a percentage of that in the absence
of cicaprost (Rab5 expression in S100; % Expression±S.E.M.). Panel C: HEK.hIP cells were pre-labelledwith the anti-HA 101R antibody for 1 h at 4 °C, prior to stimulationwith vehicle or
1 μM cicaprost at 37 °C for 0–4 h. Cells were ﬁxed and permeabilized prior to detection of HA-tagged hIPs, with anti-mouse AlexaFluor594 conjugated secondary antibody, and
endogenous Rab5 with anti-Rab5 (S-19) and anti-rabbit AlexaFluor488 conjugated secondary antibody, using Carl Zeiss Lazer Scanning System LSM510 and Zeiss LSM Imaging
software. Data presented are representative images from 3 independent experiments from which at least 10 ﬁelds were viewed at ×63 magniﬁcation, where the horizontal bar
represents 10 μm. The reader is referred to the web version of this article to see color images of this ﬁgure.
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hIP and Rab5a evident (Fig. 2A, Rab5WT, 0 h). Following stimulation of
cells with cicaprost for 2 h, there was profound relocalization of the hIP
away from the cell surface to enlarged vesicular, Rab5a positive
endosomes with signiﬁcant co-localization evident in the over-laid
images (Fig. 2A, Rab5WT, 2 h). Hence, these data indicate that the hIP
located at the cell surface internalizes to intracellular Rab5-positive
endosomes in response to cicaprost stimulation. However, the experi-
mental approach of pre-immunolabelling the hIPs expressed at the cell
surface does not examine the agonist-dependent colocalization or
association of any pre-existing intracellular pools of the hIP with Rab5.In cells over-expressing the dominant negative Rab5aS34N, the pre-
immunolabelled hIP was exclusively expressed at the cell surface, as
expected, in the absence of agonist stimulation while GFP-Rab5aS34N
exhibited diffuse intracellular staining associated with signiﬁcantly
smaller vesicles than those associated with the Rab5aWT (Figs. 2A and
B, GFP). Whilst incubation of the cells over-expressing Rab5aS34N with
cicaprost for 2 h led to internalization of the hIP, consistent with the
ELISA-based internalization studies the extent of relocalization of the
hIP away from the plasma membrane was signiﬁcantly impaired and
the pattern of intracellular staining was more diffuse, lacking the
distinct vesicular pattern observed in the HEK.hIP cells expressing the
1921M.B. O'Keeffe et al. / Biochimica et Biophysica Acta 1783 (2008) 1914–1928wild type Rab5a (Fig. 2B, Anti-HA). Upon agonist stimulation, the
Rab5aS34N did coalesce into more punctate structures but they were
not as numerous nor did they exhibit clearly deﬁned ring-like vesicular
structures, as per the wild type Rab5a. In the overlaid image there was
some evidence of co-localization, as indicated by the arrows, but the
majority of the hIP did not co-localizewith Rab5aS34N (Fig. 2B, overlay).
In the absence of agonist, the GTPase-defective Rab5aQ79L primarily
localized to pre-formed enlarged vesicular endosomes and showed no
signiﬁcant co-localization with the hIP expressed on the cell surface
(Fig. 2C). Furthermore, stimulation of cells with cicaprost led to a
signiﬁcant increase in the size of the Rab5aQ79L-positive endosomal
structures (Fig. 2C, GFP). Concomitant with this, pre-immunolabelled
cell surface hIP internalized in response to cicaprost stimulation into
intracellular vesicular endosomes thatweremarkedly increased in size
compared to those in cells over-expressing Rab5awt (Fig. 2C, Anti-HA).
In the overlaid images, it was evident that the internalized hIP almost
exclusively co-localized with the GFP-Rab5aQ79L in those enlarged
endosomes (Fig. 2C, overlay).
To further examine the role of Rab5a in agonist-induced inter-
nalization of hIP, we next investigated the time-dependent internaliza-
tion and co-localization of the hIP to Rab5a positive endosomes over a
4 h time course (Fig. 3). As in the previous experiment, cell surface HA-
tagged hIPs were pre-immunolabelled prior to stimulation with
cicaprost to follow their internalization into the Rab5a positive
endosomes. In the absence of agonist, the pre-labelled hIPwas detected
exclusively at the cell surfacewhile, in response to cicaprost stimulation
it quickly re-localized away from the plasma membrane and inter-
nalized to enlarged Rab5a positive endosomes in a time-dependentFig. 5. Co-immunoprecipitation of Rab5a with the hIP. HEK.hIP cells, or as controls, HEK
Rab5aQ79L, were incubated with either the vehicle (−) or 1 μM cicaprost (+) at 37 °C for 2 h, pr
resolved by SDS-PAGE and were either immunoblotted (IB) versus anti-Rab5 antibody (uppe
panels. Aliquots of whole cell lysates (approx. 50 μg/lane) were also resolved by SDS-PAGE an
molecular size markers are indicated to the left of the panels. Results presented are represemanner (Fig. 3, Anti-HA). Even at 30minpost-agonist stimulation, there
was evidence that the hIP and Rab5a co-localized to the cell surface and
to vesicles just inside the cell membrane (Fig. 3, 0.5 h; indicated by the
arrows) while at 1 h–2 h post-stimulation, there was almost complete
loss of cell surface receptors and increased association with Rab5a-
positive endosomes of increased size and proximity from the plasma
membrane (Fig. 3,1 h;Anti-HA). Itwasnotable that the time-dependent
internalization of the hIP observed in the immunolocalization assays
paralleled that observed in the ELISA-based assays, where maximum
loss of cell surface expression is achieved by 1 h. Furthermore, con-
sistent with the latter, following 4 h stimulation with cicaprost, while
the hIP was predominantly co-localized to Rab5a positive endosomes
there was also evidence that some of the pre-labelled receptor had
recycled back to the plasma membrane as evidenced by its increased
detection at the cell surface (Fig. 3, 4h).
3.3. hIP-mediated activation of Rab5
Rab GTPases act as molecular switches, cycling between active
GTP-bound and inactive GDP-bound states [45]. The activated form is
membrane bound and, after inactivation by their speciﬁc GTPase
activating protein(s) (GAPs), the GDP-bound Rab is extracted from the
membrane by their speciﬁc GDP-dissociation inhibitor(s) (GDIs) and
recycled back to the cytosol to await further signaling [46,47]. To
address whether hIP signaling may actually lead to direct activation or
engagement of Rab5, HEK.hIP cells were stimulated with cicaprost
over a 4 h time course prior to their fractionation into crude mem-
brane/particulate (P100) and cytosolic/soluble (S100) fractions to293 cells, transiently transfected with pEGFPCI:Rab5a, pEGFPC1:Rab5aS34N, pEGFPC1:
ior to immunoprecipitation with anti-HA 101R antibody. Immunoprecipitates (IP) were
r panels) or anti-HA 3F10-HRP antibody (middle panels), as indicated to the right of the
d immunoblotted with anti-Rab5 antibody (lower panels). The relative positions of the
ntative of at least 3 independent experiments.
Fig. 6. Cicaprost-induced Internalization by the hIPΔ312 and hIPΔ307. Panel A: HEK.hIP,
HEK.hIPΔ312 and HEK.hIPΔ307 cells were stimulated with 1 μM cicaprost for 0–4 h at
37 °C. Panel B: HEK.hIPΔ312 cells transiently co-transfected with either pCMV5:Rab5a or
pcDNA were stimulated with 1 μM cicaprost for 0–4 h at 37 °C. Panels A and B:
expression of cell surface HA-tagged hIPs was detected by the ELISA-based assay using
anti-HA 101R antibody, as described in experimental procedures. Results presented are
expressed as mean cell surface expression as a percentage of that at 0 h (% cell surface
expression±S.E.M.) as a function of time (h). Results are representative of at least three
independent experiments, each carried out in triplicate.
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of Rab5. In the absence of agonist stimulation, therewas almost a 50: 50
distribution of Rab5 protein located between the cytosol and
membrane fractions (Fig. 4A, upper panels). Whilst there was no
change in the overall level of Rab5 protein expression over the duration
of cicaprost stimulation, therewas a signiﬁcant decrease in the levels of
Rab5 in the S100 fraction as early as 30min,which continued to decrease
to barely detectable levels at 2–3 h post agonist stimulation (Figs. 4A
and B). Moreover, at 4 h post-agonist stimulation therewas evidence of
signiﬁcant Rab5 recycling back to the S100 fraction (Fig. 4A, upper
panels; Fig. 4B). These data suggest that agonist-dependent activation
of the hIP leads to direct time-dependent activation of Rab5 leading to
its net translocation from the cytosolic/soluble fraction leading to its
activation. Failure to detect corresponding agonist-dependent increases
in Rab5 expression in the P100 fractions owing to its translocation from
the S100 fractions, except at the 2 h time point, was most likely simply
due to the saturation of the chemiluminescence detection system
owing to the already high levels of Rab5 associated with the P100
fraction, even in the absence of agonist. It was also notable that the
time-dependent activation/translocation of Rab5 from the S100 fraction
almost paralleled that observed in the ELISA-based internalizations and
the immunolocalizationswhereby the activation of Rab5 in response to
hIP signaling was both rapid (~ 30 min) and transient (~3 h).
Similar to Rab5, the molecular chaperone protein HDJ-2 is an
isoprenylated protein that is dually located in the membrane (P100) and
soluble/cytosolic (S100) fractions of the cell [48]. Hence, to further
conﬁrm the speciﬁcity of the cicaprost-induced translocation of Rab5
from the soluble fractions, we also examined the expression of HDJ-2
protein in the various subcellular fractions as a function of cicaprost
stimulation by rescreening the Rab5 immunoblots with anti-HDJ-2
antibody (Fig. 4A, lower panels). HDJ-2 protein was readily detected in
both the S100 and P100 fractions under basal conditions, but unlike that of
the Rab5 GTPase, it did not undergo altered subcellular relocation in
response to cicaprost stimulation (Fig. 4A). These data conﬁrm the
speciﬁcity of the Rab5 data and, moreover, conﬁrm that the observed
decline in Rab5 expression in the S100 fractions owing to its translocation
from the cytosolic fractions was indeed a cicaprost-induced event and
was not due to lack of uniformity in protein loading, for example.
In light of the latter evidence that endogenous Rab5 may be
activated in response to cicaprost stimulation, we next sought to
examine the agonist-induced co-localization of endogenous Rab5
with the hIP. As in the previous experiments, cell surface HA-tagged
hIPs were pre-immunolabelled with anti-HA 101R prior to cicaprost
stimulation to follow their internalization, whereas endogenous Rab5
was detected post-stimulation and ﬁxation, under permeabilizing
conditions using anti-Rab5 (S-19). The pre-labelled hIP was detected
exclusively at the cell surface, as expected, and thereafter re-localized
away from the plasma membrane to endocytic vesicles in a time-
dependent manner in response to cicaprost (Fig. 4C, Anti-HA).
Furthermore, internalization led to an almost complete loss of cell
surface hIP at 2 h post cicaprost stimulation (Fig. 4C, Anti-HA, 2 h),
with evidence of recycling back to the cell surface at 4 h (Fig. 4C, Anti-
HA, 4 h). In the absence of agonist (Fig. 4C, Anti-Rab5, 0 h),
endogenous Rab5 exhibited punctuate intracellular staining, with no
evidence of co-localization with the pre-labelled cell-surface hIPs. In
response to cicaprost, Rab5 positive vesicles became more pro-Table 1
Radioligand binding data




Radioligand binding assays were carried out on HEK 293 cells stably over-expressing
HA-tagged forms of hIP, hIPΔ307 and hIPΔ312 using the IP agonist [3H]iloprost (4 nM;
15.3 Ci/mmol) and 75 μg of whole cell protein/assay.nounced and co-localized with the hIP, as observed in the overlaid
image (Fig. 4C, Overlay, 2 and 4 h). Hence, these data conﬁrm that cell
surface hIPs can internalize to native Rab5-positive endosomes in
response to cicaprost stimulation.
3.4. Co-immunoprecipitation of Rab5a with hIP
Taken together, data herein have established that the hIP undergoes
signiﬁcant time-dependent internalization in response to cicaprost
stimulation; over-expression of Rab5a increases that internalization;
the internalized hIP co-localizes to Rab5a positive endosomes and
agonist stimulation leads to direct translocation-dependent activation
of Rab5. Bearing this inmind, through a series of co-immunoprecipita-
tions, itwas next sought to investigatewhether the hIPmayphysically/
directly interact with Rab5, such as in response to agonist-stimulation.
To this end, HEK.hIP cells were co-transfected with plasmids encoding
GFP-tagged forms of Rab5a, Rab5aS34N and Rab5aQ79L and their
presence in the anti-HA-hIP immunoprecipitates investigated as a
function of agonist-stimulation. In the absence of agonist-stimulation,
both recombinant GFP-Rab5a (55 kDa) and endogenous Rab5 (25 kDa)
proteins were readily detected following immunoprecipitation of the
hIPwith anti-HA antibody,while no such proteinswere detected in the
corresponding immunoprecipitates from either the parental HEK 293
cells (Fig. 5; upper panel) or from control HEK.β-Gal cells (data not
shown). Furthermore, following cicaprost stimulation, there was an
increase in the amount of both GFP-Rab5a and endogenous Rab5
associated with the hIP immunoprecipitates (Fig. 5; upper panel). The
increase in immunoprecipitation of Rab5a in response to agonist was
not due to an increase in hIP or Rab5a expression levels (data not
shown and Fig. 5; lower panel) or in the level of the hIP present in the
anti-HA immunoprecipitates per se (Fig. 5; middle panel) and, hence,
was due to enhanced interaction between hIP and Rab5a. Similarly,
immuno-detection with anti-GFP showed that the hIP and Rab5a
interaction was enhanced in response to agonist (data not shown).
1923M.B. O'Keeffe et al. / Biochimica et Biophysica Acta 1783 (2008) 1914–1928Co-immunoprecipitation of the GTP-binding defective variant
Rab5aS34N was also observed with the hIP even in the absence of
agonist (Fig. 5; upper panel). The extent of association between the hIP
and Rab5aS34N was similar to that of wild type Rab5a (Fig. 5; upper
panel) as were the amount of hIP present in the immunoprecipitates
and the levels of GFP-Rab5a and -Rab5aS34N over-expression in the
HEK.hIP cells (Fig. 5, middle and lower panels, respectively).
Furthermore, agonist stimulation caused an increased association
between the hIP and Rab5aS34N (Fig. 5; upper panel). Likewise, the
constitutively active, GTPase defective Rab5aQ79L co-immunoprecipi-
tated with the hIP to levels that were somewhat higher than that of
the wild type Rab5a even in the absence of agonist (Fig. 5, upper
panel). Furthermore, cicaprost-stimulation caused a further increase
in hIP: Rab5aQ79L association (Fig. 5, upper panel). Taken together,
these data conﬁrm that the hIP can physically and constitutivelyFig. 7. Cicaprost-induced Co-localisationof hIPΔ312 andhIPΔ307with Rab5a.HEK.hIP (panel A), H
Rab5a, were pre-labelled with anti-HA 101R primary antibody for 1 h at 4 °C; thereafter, cells
(2 h), as indicated. Cells were ﬁxed and permeabilized prior to detection of HA-tagged hIPs, w
expression using Carl Zeiss Lazer Scanning System LSM510 and Zeiss LSM Imaging software. D
least 10 ﬁelds were viewed at ×63 magniﬁcation, where the horizontal bar represents 10 μm.interact with Rab5a in the absence of agonist but that there is an
increased association in response to agonist activation. Moreover, hIP:
Rab5a interaction is somewhat independent of the guanine nucleotide
(GDP/GTP) binding status suggesting that the Switch I and II domains
of Rab5 do not greatly inﬂuence that interaction.
3.5. Importance of the C-tail of the hIP for agonist-induced internalization
The prostacyclin receptor (IP) is somewhat unique among the
superfamily of GPCRs in that it undergoes isoprenylation, or more
speciﬁcally farnesylation, within its ‘-CAAX’ motif located within its
carboxyl-terminal (C)-tail domain [15,16,40,49]. Consistent with a role
for isoprenylation for IP function, impairment of isoprenylation
signiﬁcantly reduces agonist-induced hIP internalization [16,40].
Moreover, in another study, it was found that deletion of a substantialEK.hIPΔ307 (panel B) or HEK.hIPΔ312 (panel C) cells, transiently transfectedwithpEGFPCI:
were either analyzed directly (0 h) or were incubated at 37 °C for 2 h with 1 μM cicaprost
ith anti-mouse AlexaFluor594 conjugated secondary antibody, and enhanced GFP:Rab5a
ata presented are representative images from 3 independent experiments fromwhich at
The reader is referred to the web version of this article to see color images of this ﬁgure.
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hIP receptor, termed “C-Del” that failed to undergo short-term agonist
sequestration [24]. Contrary to the latter, Haase et al., found that
deletion of the terminal 68 residues did not signiﬁcantly affect the
ability of the hIP to undergo long-term agonist-induced internalization
[39]. Hence, it is evident there is substantial conﬂict in the literature
regarding both themode(s) of agonist-induced internalization of the IP
and, more speciﬁcally, regarding the possible requirement for and/or
involvement of its C-tail domain in that internalization [16,24,39,50].
Bearing this in mind, we next sought to investigate cicaprost-induced
internalization by two previously characterized truncation variants of
the hIP, namely hIPΔ312 (devoid of the terminal residues 312–386,
including the ‘-CAAX’ motif) and hIPΔ307 (devoid of the terminal
residues 307–386, including the palmitoylated residues at Cys308 and
Cys311 and the ‘-CAAX’ motif; [17]).
Initially, both the HEK.hIPΔ312 and HEK.hIPΔ307 cell lines [17] were
conﬁrmed to express near equivalent levels of the hIPΔ312 and hIPΔ307,
respectively, as assessed by radioligand binding (Table 1) and,
consistent with previous reports [16], it was conﬁrmed that their
relative afﬁnities for [3H]iloprost (Kd) or maximal expression (Bmax)
were not signiﬁcantly different to those of the wild type hIP ([16] and
data not shown). However, in examining agonist-induced internaliza-
tion to monitor net changes in over-all cell surface expression, it was
evident that the pattern and proﬁle of trafﬁcking by both the hIPΔ312
and hIPΔ307 varied considerably andwere signiﬁcantly different to that
of the wild type hIP (Fig. 6A, pb0.0001 and pb0.0001, respectively;
ANOVA). More speciﬁcally, the hIP, hIPΔ312 and hIPΔ307 each under-
went internalization during the initial 60 min post-cicaprost stimula-
tion. However, after 1 h, while the hIPWT continued to be internalizedFig. 8. Co-immunoprecipitation of Rab5a with hIPΔ312 and hIPΔ307. HEK.hIPΔ312 and HEK.hIPΔ
incubated with either the vehicle (−) or 1 μM cicaprost (+) at 37 °C for 2 h, prior to immunopr
PAGE andwere either immunoblotted (IB) versus anti-Rab5 antibody (upper panels) or anti-H
whole cell lysates (approx. 50 μg/lane) were also resolved by SDS-PAGE and immunoblotte
markers are indicated to the left of the panels. Results presented are representative of at leup until the 3 h time-point, cell surface expression of both hIPΔ312
(p≤0.0001) and hIPΔ307 (p≤0.0001) signiﬁcantly increased at 90 min,
showing 100% cell surface expression, before a further decrease in cell
surface expression at 2 h (Fig. 6A). By 4 h post-agonist stimulation, the
hIP, hIPΔ312 and hIPΔ307 each displayed increased cell surface expres-
sion suggesting their recycling back to the cell surface, consistent with
our previous ﬁndings with the hIP (Fig. 1A). It was also notable that in
the case of both the hIPΔ312 (p≤0.005) and hIPΔ307 (p≤0.0001), there
were signiﬁcantlymore receptors located at the cell surface at 4 h post-
agonist stimulation, compared to the wild type hIP.
Hence, these ELISA data herein suggested that both the hIPΔ312 and
hIPΔ307 display signiﬁcantly alteredpatterns of trafﬁcking to and from the
plasma membrane relative to the hIP. Therefore, we next investigated
whether Rab5 could promote and/or maintain the internalization of
either hIPΔ312 or hIPΔ307. Over-expression of Rab5a had no signiﬁcant
effecton the level or general patternof agonist-induced internalizationby
the hIPΔ312 (Fig. 6B, p=0.0573; ANOVA) or the hIPΔ307 (data not shown)
over a 4 h incubationperiod. It was notable therewas a delay in the initial
rate of internalization by the hIPΔ312 in the presence of exogenous Rab5a
(Fig. 6B) relative to that observed in its absence (Fig. 6A), where max-
imum internalization was achieved at 90 min in the former (Fig. 6B),
compared to 60min for the latter (Fig. 6A). This delaywasmost likely due
to the transfection process and/or recovery of the cells post-transfection
rather than a Rab5a-mediated effect as the control pcDNA3-transfected
cells exhibited a similar delay in internalization for both the hIPΔ312
(Fig. 6B) and hIPΔ307 (data not shown). Hence, unlike that of the hIP, over-
expression of Rab5a did not speciﬁcally augment or alter the trafﬁcking
by the hIPΔ312 or hIPΔ307, suggesting that the C-tail domain may in
someway be involved in the interaction with Rab5a.307 cells, or as a control, HEK 293 cells, transiently transfected with pEGFPCI:Rab5a, were
ecipitationwith anti-HA 101R antibody. Immunoprecipitates (IP) were resolved by SDS-
A 3F10-HRP antibody (middle panels), as indicated to the right of the panels. Aliquots of
d with anti-Rab5 antibody (lower panels). The relative positions of the molecular size
ast 3 independent experiments.
Fig. 9. Cicaprost-induced re-location of Rab5 in EA.hy 926 cells. EA.hy 926 cells were stimulated with vehicle or 1 μM cicaprost at 37 °C for 0–4 h. Cells were ﬁxed and permeabilized
prior to detection of endogenous expression of Rab5 with rabbit anti-Rab5 and anti-rabbit AlexaFluor488 conjugated secondary antibodies expression using a Carl Zeiss Lazer
Scanning System LSM510 and Zeiss LSM Imaging software. Data presented are representative images from 3 independent experiments fromwhich at least 10 ﬁelds were viewed at
×63 magniﬁcation, where the horizontal bar represents 10 μm. The reader is referred to the web version of this article to see color images of this ﬁgure, where relevant.
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mediated internalization of hIP, we investigated whether the hIPΔ312
and hIPΔ307 co-localize with Rab5 endosomes in response to agonist, as
observed with the wild type hIP (Figs. 2 and 7A). In the absence of
cicaprost, both the pre-immunolabelled hIPΔ312 and hIPΔ307 were
detected at the cell surface while GFP-Rab5a exhibited punctuate
intracellular staining, consistentwith small endocytic vesicleswith little
co-localization between either hIPΔ312 or hIPΔ307 and Rab5a (Figs. 7B
and C; 0 h). Whilst the hIPΔ312 and hIPΔ307 each moved from the cell
surface into the small endosomal type vesicles, showing some co-
localization with Rab5a in response to cicaprost stimulation (Figs. 7B
andC, 2h), itwas also evident that the extentof their internalizationwas
signiﬁcantly impaired relative to the hIP. It was also noteworthy that
from several independent experiments that the size of the endosomal
vesicles generated in response to cicaprost stimulation in HEK.hIPΔ312
and HEK.hIPΔ307 cells were smaller and closer to the cell surface than
those generated in HEK.hIP cells under similar incubation conditions
(1 μMcicaprost, 2 h; Figs. 2 and 7A). In agonist-treated HEK.hIP cells the
endocytic vesicles were on average 2–3 μm in diameter whilst those in
HEK.hIPΔ312 and HEK.hIPΔ307 reached a maximum diameter of 1.5 μm.
From co-immunoprecipitation studies it was conﬁrmed that in the
absence of agonist-stimulation, both recombinant GFP-Rab5a (55 kDa)
andendogenousRab5 (25kDa)proteinswere readilydetected in the anti-
HA-immunoprecipitates fromHEK.hIP, HEK.hIPΔ312 andHEK.hIPΔ307 cells
to near comparable levels, while no such proteins were detected in the
equivalent immunoprecipitates from either the parental HEK 293 cells
(Fig. 8; upper panel) or from control HEK.β-Gal cells (data not shown).
This hIP:Rab5a interactionwas further enhanced following stimulation of
HEK.hIP, HEK.hIPΔ312 and HEK.hIPΔ307 cells with 1 μM cicaprost for 2 h.
These data conﬁrm that both thewild type hIP and its truncated variants
hIPΔ312 and hIPΔ307 were capable of directly interacting with Rab5a, both
in an agonist-independent and -dependent manner.
3.6. Cicaprost-induced movement of Rab5 in EA.hy 926 cells
In order to further investigate the involvement of Rab5 in the in-
ternalization of the hIP, we also examined changes in the localization of
Rab5 endogenously expressed in endothelial cells, namely in the human
endothelial EA.hy 926 cell line [44], in response to stimulation of
endogenous hIPs with cicaprost. In the absence of agonist, Rab5
exhibited punctuate staining, with little evidence of its expression at
the cell surface (Fig. 9, 0 h). In response to cicaprost-stimulation, the
Rab5-positive vesicles becomesubstantiallymorepronounced in a time-
dependentmanner such that at 2 hpost-stimulation, they coalesced into
fewer but signiﬁcantly larger vesicles (Fig. 9, 2 and 4 h). These data in
endothelial EA.hy 926 cells provide further independent evidence of the
role of Rab5 in agonist-dependent internalization of the hIP.
4. Discussion
A critical feature of the GPCR signaling paradigm is desensitization,
the process that regulates the signal in response to temporary orsustained agonist stimulation [18,19]. Rapid desensitization is
achieved by receptor phosphorylation such as by second messenger-
dependent protein kinase (PK) A or PKC or by GRKs [30,51]. Another
means by which GPCRs are critically regulated post-agonist activation
is sequestration or internalization of the GPCR from the plasma
membrane into the various intracellular compartments making them
unavailable for further stimulation of the primary signaling path, at
least. The best characterizedmechanism of GPCR internalization is the
clathrin-mediated endocytic pathway where, classically, GRK phos-
phorylation of the agonist-engaged GPCR leads to the recruitment of
β-arrestin(s) which, in turn, act as intermediary adaptor proteins
targeting the receptor to clathrin coated vesicles [38,52–54]. However,
it is well recognized that β-arrestin-mediated internalization of GPCRs
via CCVs may represent only one of the many pathways leading to
GPCR endocytosis [55–57].
The human prostacyclin receptor (hIP) has been shown to undergo
rapid agonist-induced, PKC-phosphorylation and desensitization of
signaling in human platelets and other cell types [20–24]. Further-
more, it undergoes rapid agonist-induced internalization by, as yet,
largely unknown mechanism(s) that are independent of PKC and the
classical GRK/β-arrestin pathway [24,58]. In the current study and
consistent with previous reports [24,58], through ELISA-based inter-
nalization assays it was conﬁrmed that hIP internalizes in response to
its agonist cicaprost in a time- and concentration-dependent manner.
From the time course assays, it was evident that most of the
internalization occurred during the initial 60 min incubation period,
with some 30–40% of the total hIP on the cell surface undergoing
internalization. Thereafter, the rate of internalization declined such
that the overall level of internalized hIP remained at approximately
40% for a duration of 3 h post-agonist stimulation while at 4 h, some
50% of the internalized hIP recycled to the cell surface. On prolonged
cicaprost stimulation (4–8 h), we observed that some 50% of the
internalized hIP failed to recycle back to the plasma membrane (data
not shown) and, therefore, reasonably assume that it underwent
agonist-induced turnover/degradation such as through onward traf-
ﬁcking of the internalized hIP to lysosomes.
However, as the ELISA-based assay is an end-point assay and can
only measure net changes in cell surface expression, we also
investigated whether the hIP may undergo agonist-induced localiza-
tion to Rab5 endosomes through more direct imaging based-studies.
Through confocal microscopy, it was demonstrated that the agonist-
stimulated hIP moves from the plasma membrane into large
intracellular punctuate type vesicles, reminiscent of CCVs or endocytic
vesicles. Alternative mediators of GPCR internalization and indeed
trafﬁcking have been identiﬁed including the Rab GTPases [30,59]. Rab
proteins are the largest subgroup of the Ras-like small GTPases with at
least 60 members identiﬁed in humans and act as molecular switches
to regulate and facilitate numerous cellular processes such as
endocytosis, intracellular vesicle transport and exocytosis [30,60,61].
Rab5 is involved in clathrin-mediated endocytosis where it is recruited
to the endocytic vesicles, sequestering ligands into clathrin-coated pits
and directing early endosome fusion [30,59,61]. Hence, herein, in view
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lization data, it was sought to determine whether Rab5 had a role in
internalization of the hIP. Through ELISA-based assays, it was
established that over-expression of Rab5a led to a signiﬁcant increase
in cicaprost-induced internalization throughout the initial 3 h duration
post-agonist stimulation but did not interfere with the level of the hIP
recycled at the 4 h time point. Furthermore, using GFP-tagged Rab5a, it
was clearly established that the hIP internalizes to and co-localizes
with Rab5a in intracellular endocytic vesicles in response to agonist
stimulation. In contrast to that observed with certain other GPCRs
[33,35], over-expression of Rab5aS34N did not appear to substantially
reduce cicaprost-induced internalization of the hIP when assessed
through the ELISA-based internalization assays. Thismay be due to the
high levels of endogenous Rab5 present in HEK 293 cell line itself, as
conﬁrmed by immunoblotting. However, contrary to the latter data,
confocal microscopy showed that, in the presence of Rab5aS34N,
agonist-internalization of the hIP differed signiﬁcantly from that
observed with the wild type Rab5a. In the presence of Rab5aS34N, the
extent of relocalization of the hIP away from the plasma membrane
was signiﬁcantly impaired and the pattern of intracellular stainingwas
more diffuse, lacking the distinct vesicular pattern typically associated
with Rab5-positive endosomes. On the other hand, in the presence of
constitutively active Rab5aQ79L, agonist-induced internalization was
signiﬁcantly increased and the internalized hIP co-localized to sub-
stantially enlarged Rab5aQ79L positive endosomes. Taken together,
these data strongly suggest that Rab5a has an active role in the
internalization of the hIP and is necessary for its efﬁcient sorting to
Rab5a-positive endosomes.
Rab GTPases cycle between active GTP-bound and inactive GDP-
bound states, controlled by guanine nucleotide exchange factors (GEFs)
andGTPase activating factors (GAPs) [61,62].MembraneboundRabs are
active and, after inactivation by their speciﬁc GAPs, the GDP-bound
Rabs become extracted from the membrane by GDP-dissociation
inhibitor (GDI) where they remain complexed, in their GDP-bound
state, ready for the next cycle of activation and recruitment to the
membrane [61,62]. Herein, through subcellular fractionation studies,
there was a substantial, time-dependent decrease in the levels of Rab5
in the soluble fraction for the initial 3 h post-agonist stimulationwhile
at 4 h, there was evidence of signiﬁcant Rab5 recycling back to the
cytosolic/S100 fraction. These data suggest that agonist-activation of the
hIP may directly couple to Rab5, promoting the release of GDI and, in
turn, stimulating membrane association and GDP/GTP exchange to
regulate hIP trafﬁcking from the cell surface to Rab5-positive
endosomes. Furthermore, these data also suggested a direct association
between the hIP and Rab5. Through co-immunoprecipitations, a direct
physical interaction between hIP and Rab5awas conﬁrmed even in the
absence of agonist but which was enhanced in response to cicaprost
stimulation, consistent with the cicaprost-induced translocation of
Rab5 from the soluble/cytosolic fraction. The reason for an apparent
discrepancy between the co-immunoprecipitation and co-localization
data is due to the way in which the two types of experiments were
performed. To monitor the role of Rab5 in agonist-induced internaliza-
tion of the hIP by confocal microscopy, cell surface hIPs were pre-
immunolabelled prior to agonist-stimulation. In response to agonist,
only changes in the subcellular localization, and subsequent colocaliza-
tion with Rab5a, of pre-labelled cell surface hIP expression was
monitored. Hence, in unstimulated cells, lack of co-localization of
Rab5a with the hIP is due to the fact that only hIPs located at the cell
surface were labelled/detected. On the other hand, in the co-
immunoprecipitations, all HA-tagged hIPs (both cell surface and
intracellular) were immunoprecipitated and hence, as is suggested
from the co-immunoprecipitations, Rab5 associates with the hIP even
in the absence of agonist. Moreover, through further co-immunopre-
cipitations, it was established that similar to the wild type Rab5a, both
Rab5aS34N and Rab5aQ79L are capable of interacting with the hIP and
that such interactions were enhanced on agonist-stimulation. Takentogether, these data clearly suggest that GTP-binding or hydrolysis may
not be a limiting factor for Rab5:hIP complex formation but from
immunolocalizations involving Rab5aS34N, GTP-loading is necessary to
drive endosome formation and hIP sorting to such endosomes.
Moreover, the translocation assays and the confocal imaging data
suggest that the hIP is not simply passive cargo in the endocytosis
process but that it directly inﬂuences the subcellular localization and
association of Rab5 with the endosomal membranes. Consistent with
that hypothesis, stimulation of endogenous hIPs expressed in the
endothelial EA.hy 926 cell line with cicaprost led to a profound, time-
dependent relocalization of endogenous Rab5 to enlarged endocytic
vesicles.
The GTPase dynamin mediates the ﬁrst steps of endosome
formation at sites of clathrin-coated vesicles (CCVs) and caveoli
[25,26]. Consistent with this, over-expression of a dominant negative
form of dynamin, namely DynK44A, partially impaired agonist-inter-
nalization of the hIP [24]. Herein, while expression of DynK44A or
Rab5aS34N partially impaired cicaprost-inducedhIP internalization, co-
expression of both factors together did not lead to further impairments
suggesting that dynamin and Rab5 regulate hIP internalization
through a commonpathway rather than through distinctmechanisms.
The internalization of numerous GPCRs has been found to be
dependent on the presence of an intact C-tail domain [63,64]. As
stated, in the case of the hIP, there is conﬂicting evidence regarding the
requirement of the C-tail domain for internalization [16,24,39]. It is
reasonable to speculate that the conﬂicting data regarding the C-tail
may be attributable to differences between the cell types employed
and the complement of proteins that make up their endocytic
machinery, as has been suggested for other receptors [65]. Hence,
herein, we sought to clarify the requirement for the C-tail in hIP
internalization in HEK 293 cells. As stated, the C-tail of the hIP is
complex being subject to both palmitoylation, at Cys308 and Cys311, and
farnesylation, at Cys383 [16,17]. Using previously characterized deletion
variants hIPΔ312 andhIPΔ307, in keepingwith theﬁndings of Smyth et al.
[24] cicaprost-induced internalization by the hIPΔ312 or hIPΔ307did not
differ substantially to that of the wild type hIP within the ﬁrst 60 min
post-agonist stimulation. However, after 60 min, cell surface expres-
sion of the truncated hIPΔ312 and hIPΔ307 variants differed signiﬁcantly
from the hIP with evidence of altered trafﬁcking or recycling, i.e., they
exhibited altered time-dependent movement to and from the cell
surface followed by further internalization, and after 4 h incubation
both hIPΔ312 and hIPΔ307 were located at the cell surface. The time-
dependent variability in the internalization and cell surface expression
of the hIPΔ312 and/or hIPΔ307 may explain the apparent conﬂict in data
between the previously reported research studies [24,39]. Moreover,
the data herein suggests that while the C-tail domain of the hIP may
not be essential for internalization per se, it does appear to be required
to maintain the internalized receptor within the endocytic pool, pre-
venting it from recycling back to the plasmamembrane, such as occurs
in the case of the hIPΔ312 and hIPΔ307 at 90 min. In contrast to that
which occurred for thewild type hIP, over-expression of Rab5a did not
inﬂuence the internalization pattern of the hIPΔ312 or hIPΔ307suggest-
ing that the C-tail may actually be involved in or required for the Rab5
interaction. Co-immunoprecipitations categorically established that
both the hIPΔ312 or hIPΔ307 are capable of directly interacting
with Rab5a and that, similar to the hIP, such interactions are en-
hanced in response to cicaprost stimulation. However, whilst deletion
of the C-tail did not inhibit interaction with Rab5a, confocal imaging
established that the truncated hIPΔ312 or hIPΔ307 had signiﬁcantly
impaired internalization and co-localization to Rab5a-positive endo-
somes. Speciﬁcally, in contrast to the distinct enlarged ring-like
vesicles observed with the internalized wild type hIP, such as at 2 h
post-agonist stimulation, the hIPΔ307 and hIPΔ312 were found asso-
ciated with signiﬁcantly smaller Rab5a positive vesicles that were
located much closer to the plasma membrane, suggestive of impaired
internalization or subsequent trafﬁcking. Taken together, these data
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not essential for Rab5a interaction, it appears to have a role in
regulating further trafﬁcking of the hIP from the Rab5-early en-
dosomes, perhaps to other Rab-containing transport vesicles, pre-
venting it from recycling to the plasma membrane in a dysregulated
manner.
Rab5 can play quite diverse roles in mediating agonist-induced
internalization of various GPCRs. In the case of the dopamine D2
receptor, internalization was accelerated by over-expression of Rab5a
and Rab5aQ79L and inhibited by Rab5aS34N [35]. β2AR internalization
was also inhibited by Rab5aS34N, preventing receptor dephosphoryla-
tion and resensitization [33]. Internalization of the neurokinin-1
receptor (NK1R) involves dynamin- and β-arrestin-dependent pro-
cesses, followed by Rab5a-mediated transport from early endosomes
to Rab4a- and Rab11a-containing recycling endosomes [66]. In this
case, over-expression of either Rab5a or its dominant negative variant
did not affect receptor internalization per se but inﬂuenced the ability
of the NK1R to translocate from superﬁcial vesicles beneath the
plasma membrane into intracellular endosomes. Likewise, agonist-
mediated internalization of the angiotensin II type 1A receptor
(AT1AR) was not affected by Rab5 protein expression despite the
formation of Rab5-AT1AR protein complexes mediated, at least in part,
by the last 10 amino acid residues of the C-tail of AT1AR itself [37].
Whilst the latter studies clearly indicate an involvement of Rab5 in
internalization/trafﬁcking of certain GPCRs, in the broader context of
the superfamily, to date it is in no way a widely recognized pheno-
menon or indeed predictable. More particularly, this is the ﬁrst study
showing a role for Rab5 in the internalization/trafﬁcking of the
prostacyclin receptor. In order to explain the role of Rab5 in the
internalization of the hIP, we propose that on agonist stimulation, the
hIP is initially recruited to CCVs at the plasma membrane. The involve-
ment of clathrin-coated pits has been conﬁrmedwhereby concanavalin
A and sucrose, inhibitors of clathrin-mediated trafﬁcking, impaired
agonist-induced internalization of the hIP in HEK 293 cells [24].
Thereafter, a proportion of the hIPs are internalized via a dynamin- and
Rab5-dependent mechanism. Confocal imaging of HEK.hIP cells over-
expressing the GFP-tagged Rab5a demonstrated that there was rapid
co-localization of the hIP to Rab5a positive vesicles at or just below the
cell surface indicating that Rab5a affects internalization of the hIP at
an early stage. Cell fractionation data herein also demonstrate that
there is signiﬁcant and rapid translocation of Rab5 from the soluble
to particulate/membrane fraction in response to cicaprost-stimulation
and, as assessed through confocal imaging, there was cicaprost-
dependent relocalization of endogenous Rab5 in EA.hy 926 cells.Whilst
multiple roles for Rab5a in endosome formation and fusion have been
identiﬁed, the role of Rab5a at the plasma membrane is being
increasingly understood [59]. From studies involving the hIPΔ312 and
hIPΔ307 variants, it appears that while the C-tail of the hIP is not
absolutely essential for the Rab5-mediated internalization, it has a role
in the onward trafﬁcking of the hIP. This suggests that there are
sequences/domains within the C-tail of the hIP that regulate the
subsequent fate of the internalized receptor. Once conveyed to Rab5-
containing endosomes, we propose that the internalized hIP is sorted
and subsequently either recycled back to the cell surface via recycling
endosomes or transported to lysosomes for degradation. These
processes are most likely facilitated by other members of the Rab
GTPase family, such as by sorting to Rab4 containing early endosomes
and/or to Rab11 containing late endosomes and in their subsequent
regulation of recycling or to Rab7 containing late endosomes and
transported to lysosomes. Through follow up studies, we are currently
investigating the role of Rab4 andRab11 inpost-endocytic sortingof the
hIP. Moreover, we are also seeking to identify the structural determi-
nants on the hIP and on Rab5a that mediate their speciﬁc interaction.
While the data presented herein provide compelling evidence for a
critical role for Rab5 in agonist-induced internalization of the hIP, they
do not exclude the possibility of other internalization pathway(s)being involved, such as via the novel cGMP phosphodiesterase 6δ
(PDE6δ)-dependent pathway recently proposed byWilson and Smyth
[67]. In this current study, we determined that the hIP is subject to
agonist-induced internalization mediated, at least in part, via a
dynamin- and Rab5a-dependent route, requiring GDP/GTP exchange
on Rab5a for hIP trafﬁcking to endosomes. Furthermore, we have
demonstrated that there is a direct interaction between the hIP and
Rab5a. Our studies reveal that the C-tail is not required for this
interaction or hIP internalization per se but suggest that there are
determining factors within the C-tail that regulate the subsequent fate
of the internalized hIP, such as during its onward agonist-induced
movement to recycling endosomes, via Rab4 or Rab11, or to lysosomes
for degradation. The results herein add signiﬁcantly to our current
understanding of the events regulating the hIP post-agonist stimula-
tion. In view of the ever-increasing recognition of the essential role of
prostacyclin and its receptor for vascular integrity and in counter-
balancing/off-setting various types of vascular diseases including
thrombosis, systemic hypertension, stroke and myocardial infarction
[5–8], these studies provide important mechanistic insights into how
hIP, and/or indeed Rab5, dysfunction may contribute to such disease
processes.
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